BPC-157 + TB-500 is a co-formulated blend pairing a gastric-derived pentadecapeptide with the actin-binding fragment of thymosin beta-4, allowing researchers to study angiogenic and cytoskeletal repair pathways in a single reagent. Supplied as a ≥99% HPLC-verified lyophilized powder for laboratory research use only.
€ 59.99
33 in stock
Third-Party Tested by Janoshik Analytical
Compound Information
Technical specifications
Co-lyophilized blend; keep sealed, dry, and protected from light
Store at a stable temperature; minimize warming/cooling cycles
Aliquot after reconstitution; avoid repeated freeze–thaw cycles
Lyophilized Powder
-20°C preferred; 2–8°C for short-term handling
Reconstituted
2–8°C
This co-formulated blend pairs two peptides that approach tissue repair from different directions. BPC-157 is a synthetic pentadecapeptide derived from a protective protein sequence found in gastric juice, studied primarily for its influence on angiogenesis, growth factor signaling, and cytoprotection. TB-500 reproduces the actin-binding motif of thymosin beta-4, and acts on the cytoskeleton — regulating the monomeric actin pool and, through it, cell migration and cytoskeletal remodeling. Because one arm is vascular and signaling-driven while the other is structural and cytoskeletal, researchers use this pairing to study how the two converge in wound-repair and tissue-regeneration models. Supplied as a high-purity co-lyophilized powder for reproducible in-vitro and approved in-vivo work. This product is for laboratory research and development purposes only and must be handled by qualified professionals. Not for human, therapeutic, or diagnostic use.
BPC-157 — Angiogenesis
Studied for its influence on vascular network formation and growth factor signaling in tissue-repair models.
TB-500 — Actin Sequestration
Reproduces the LKKTETQ motif that binds monomeric G-actin, regulating the pool available for polymerization.
Complementary Mechanisms
One arm is vascular and signaling-driven, the other structural and cytoskeletal — making the pairing genuinely non-redundant.
Cell Migration Assays
Commonly used together in scratch and transwell assays examining directional motility and wound closure.
Single-Reagent Convenience
A fixed-ratio co-lyophilized blend removes the variability of preparing and combining two separate stocks.
≥99% HPLC Purity
Both components are HPLC-verified and co-lyophilized, ensuring a consistent ratio across every vial.
They act through different mechanisms — BPC-157 on angiogenesis and growth factor signaling, TB-500 on the actin cytoskeleton. The pairing is non-redundant, which is what makes it useful for studying convergent repair pathways.
BPC-157 is a synthetic 15-residue peptide based on a protective protein sequence found in gastric juice, studied for its influence on angiogenesis and cytoprotection.
TB-500 is a seven-residue peptide reproducing the actin-binding motif of thymosin beta-4. It binds monomeric G-actin, regulating the pool available for polymerization into filaments.
No. This product has not been evaluated by the FDA and is strictly intended for research and development purposes by qualified professionals only.